Day, John W.
Stanford Medicine
7 papers on CoChatORCID 0000-0002-0086-9529
Most cited papers
- Verified
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine
Neurogenetic and Muscular Disorders ResearchLysosomal Storage Disorders Research
Cited by 1,433
- Verified
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Day, J. W., Finkel, R. S., Chiriboga, C. A., Connolly, A. M., Crawford, T. O., Darras, B. T., Iannaccone, S. T., Kuntz, N. L., Peña, L. D. M., Shieh, P. B., et al. (2021) · The Lancet Neurology
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 494
- Verified
MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain
Goodwin, M., Mohan, A., Batra, R., Lee, K.-Y., Charizanis, K., Gómez, F. J. F., Eddarkaoui, S., Sergeant, N., Buée, L., Kimura, T., et al. (2015) · Cell Reports
RNA Research and SplicingGenetic Neurodegenerative Diseases
Cited by 151
- Verified
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
Day, J. W., Mendell, J. R., Mercuri, E., Finkel, R. S., Strauss, K. A., Kleyn, A., Tauscher-Wisniewski, S., Tukov, F. F., Reyna, S. P., & Chand, D. H. (2021) · Drug Safety
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 119
- Verified
Telomere shortening is a hallmark of genetic cardiomyopathies
Chang, A. C. Y., Chang, A. C. H., Kirillova, A., Sasagawa, K., Su, W., Weber, G., Lin, J., Termglinchan, V., Karakikes, I., Seeger, T., et al. (2018) · Proceedings of the National Academy of Sciences
Telomeres, Telomerase, and SenescenceCardiomyopathy and Myosin Studies
Cited by 91
- Verified
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
Hilbert, J. E., Barohn, R. J., Clemens, P. R., Luebbe, E. A., Martens, W. B., McDermott, M. P., Parkhill, A. L., Tawil, R., Thornton, C. A., Moxley, R. T., et al. (2017) · Neurology
Genetic Neurodegenerative DiseasesGastrointestinal motility and disorders
Cited by 70
- Verified
Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec
Day, J. W., Finkel, R. S., Mercuri, E., Swoboda, K. J., Menier, M., van Olden, R., Tauscher-Wisniewski, S., & Mendell, J. R. (2021) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research
Cited by 48
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free